rs587776665
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_001372051.1(CASP8):c.1228_1229delGT(p.Val410PhefsTer28) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000434 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
 Genomes: 𝑓 0.000020   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.0000027   (  0   hom.  ) 
Consequence
 CASP8
NM_001372051.1 frameshift
NM_001372051.1 frameshift
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  4.95  
Publications
1 publications found 
Genes affected
 CASP8  (HGNC:1509):  (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008] 
CASP8 Gene-Disease associations (from GenCC):
- autoimmune lymphoproliferative syndrome type 2BInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease. 
PM2
Very rare variant in population databases, with high coverage; 
PP5
Variant 2-201285237-CTG-C is Pathogenic according to our data. Variant chr2-201285237-CTG-C is described in ClinVar as Pathogenic. ClinVar VariationId is 7761.Status of the report is no_assertion_criteria_provided, 0 stars. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CASP8 | NM_001372051.1  | c.1228_1229delGT | p.Val410PhefsTer28 | frameshift_variant | Exon 8 of 9 | ENST00000673742.1 | NP_001358980.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000197  AC: 3AN: 152220Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3
AN: 
152220
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.00000274  AC: 4AN: 1461892Hom.:  0   AF XY:  0.00000275  AC XY: 2AN XY: 727246 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
4
AN: 
1461892
Hom.: 
 AF XY: 
AC XY: 
2
AN XY: 
727246
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33480
American (AMR) 
 AF: 
AC: 
0
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53420
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
4
AN: 
1112010
Other (OTH) 
 AF: 
AC: 
0
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.488 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000197  AC: 3AN: 152220Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 74360 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3
AN: 
152220
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
0
AN XY: 
74360
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41444
American (AMR) 
 AF: 
AC: 
0
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10628
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
3
AN: 
68040
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.592 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Pathogenic 
Submissions summary: Pathogenic:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Hepatocellular carcinoma    Pathogenic:1 
Jan 06, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.